US Stock Futures Edge Higher Ahead Of Economic Data
US stock futures traded slightly higher in early pre-market trade. Data on consumer spending for January will be released at 8:30 a.m. ET, while the Markit PMI manufacturing index for February will be released at 9:45 a.m. ET. The ISM manufacturing composite index for February and construction spending data for January will be released at 10:00 a.m. ET. Futures for the Dow Jones Industrial Average climbed 7 points to 18,134.00, while the Standard & Poor's 500 index futures rose 0.30 points to 2,103.10. Futures for the Nasdaq 100 index gained 5.25 points to 4,447.75.
A Peek Into Global Markets
European markets were lower today, with the Spanish Ibex Index dropping 0.21%, STOXX Europe 600 Index falling 0.43% and German DAX 30 index dropping 0.03%. French CAC 40 Index dipped 0.71% and London's FTSE 100 Index fell 0.12%.
In Asian markets, Japan's Nikkei Stock Average rose 0.15%, Hong Kong's Hang Seng Index climbed 0.26%, China's Shanghai Composite Index climbed 0.78% and India's BSE Sensex jumped 0.33%.
Analysts at Atlantic Equities downgraded International Business Machines Corporation (NYSE: IBM) from Neutral to Underweight, according to sources.
IBM's shares climbed 0.67% to close at $161.94 on Friday.
- NXP Semiconductors N.V. (NASDAQ: NXPI) and Freescale Semiconductor, Ltd. (NYSE: FSL) today announced that they have entered into a definitive agreement under which NXP will merge with Freescale in a transaction which values the combined enterprise at just over $40 billion. To read the full news, click here.
- Nielsen N.V. (NYSE: NLSN) today announced that Valcon Acquisition Holding (Luxembourg) S.à r.l. intends to offer for sale in an underwritten secondary offering 8,000,000 shares of its common stock pursuant to the Company's shelf registration statement filed with the Securities and Exchange Commission. To read the full news, click here.
- Shire plc (NASDAQ: SHPG) announced today that the company has submitted a New Drug Application (NDA) with the U. S. Food and Drug Administration for its investigational compound lifitegrast for the treatment of signs and symptoms of dry eye disease in adults. To read the full news, click here.
- Alkermes plc (NASDAQ: ALKS) today announced a new drug candidate, ALKS 7119, for the treatment of agitation in patients with Alzheimer's disease, major depressive disorder (MDD) and other central nervous system (CNS) indications. To read the full news, click here.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.